Previous close | 36.29 |
Open | 36.39 |
Bid | 38.06 x 38700 |
Ask | 38.08 x 105300 |
Day's range | 36.39 - 38.11 |
52-week range | 30.16 - 43.38 |
Volume | |
Avg. volume | 361,692 |
Market cap | 11.059B |
Beta (5Y monthly) | 0.86 |
PE ratio (TTM) | 20.82 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.19 (3.28%) |
Ex-dividend date | 17 May 2024 |
1y target est | N/A |
FMS introduces NxStage VersiHD with GuideMe Software to simplify home dialysis and grow its patient base in the United States.
FMS continues to gain traction through its broad dialysis product and service portfolio. Ongoing macro challenges raise concerns.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.